Cross‐Cohort Gut Microbiome Signatures of Irritable Bowel Syndrome Presentation and Treatment

Cross‐Cohort Gut Microbiome Signatures of Irritable Bowel Syndrome Presentation and Treatment

Abstract Irritable bowel syndrome (IBS) is a prevalent disorder of gut‐brain interaction without a reliable cure. Evidence suggests that an alteration of the gut microbiome may contribute to IBS pathogenesis, motivating the development of microbiome‐targeted therapies to alleviate IBS symptoms. Howe...

Full description

Saved in:
Bibliographic Details
Main Authors: Junhui Li, Tarini Shankar Ghosh, Elke Arendt, Fergus Shanahan, Paul W. O'Toole
Format: Article
Language:English
Published: Wiley 2024-11-01
Series:Advanced Science
Subjects:
diet
gut microbiome
irritable bowel syndrome
oral bacterial translocation
rifaximin
Online Access:https://doi.org/10.1002/advs.202308313
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/advs.202308313

Similar Items